These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38734319)

  • 1. Integration of proteomic and metabolomic analysis reveal distinct metabolic alterations of prostate cancer-associated fibroblasts compared to normal fibroblasts from patient's stroma samples.
    Bordanaba-Florit G; Royo F; Albóniga OE; Clayton A; Falcón-Pérez JM; Webber J
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167229. PubMed ID: 38734319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
    Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
    Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression.
    Hsieh CL; Liu CM; Chen HA; Yang ST; Shigemura K; Kitagawa K; Yamamichi F; Fujisawa M; Liu YR; Lee WH; Chen KC; Shen CN; Lin CC; Chung LWK; Sung SY
    Sci Rep; 2017 Aug; 7(1):9065. PubMed ID: 28831065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.
    Webber JP; Spary LK; Mason MD; Tabi Z; Brewis IA; Clayton A
    Oncotarget; 2016 Apr; 7(15):20124-39. PubMed ID: 26934553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of urinary extracellular vesicles from prostate cancer patients on the transcriptomes of cancer-associated and normal fibroblasts.
    Sadovska L; Zayakin P; Bajo-Santos C; Endzeliņš E; Auders J; Keiša L; Jansons J; Lietuvietis V; Linē A
    BMC Cancer; 2022 Oct; 22(1):1055. PubMed ID: 36224527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblasts.
    Nardi F; Fitchev P; Franco OE; Ivanisevic J; Scheibler A; Hayward SW; Brendler CB; Welte MA; Crawford SE
    J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29792311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.
    Ting HJ; Deep G; Jain AK; Cimic A; Sirintrapun J; Romero LM; Cramer SD; Agarwal C; Agarwal R
    Mol Carcinog; 2015 Sep; 54(9):730-41. PubMed ID: 24615813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
    Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
    Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.
    Bohonowych JE; Hance MW; Nolan KD; Defee M; Parsons CH; Isaacs JS
    Prostate; 2014 Apr; 74(4):395-407. PubMed ID: 24338924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.
    Nguyen EV; Pereira BA; Lawrence MG; Ma X; Rebello RJ; Chan H; Niranjan B; Wu Y; Ellem S; Guan X; Wu J; Skhinas JN; Cox TR; Risbridger GP; Taylor RA; Lister NL; Daly RJ
    Mol Cell Proteomics; 2019 Jul; 18(7):1410-1427. PubMed ID: 31061140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line.
    Kaur SP; Verma A; Lee HK; Barnett LM; Somanath PR; Cummings BS
    Sci Rep; 2021 Apr; 11(1):9262. PubMed ID: 33927256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate.
    Orr B; Riddick AC; Stewart GD; Anderson RA; Franco OE; Hayward SW; Thomson AA
    Oncogene; 2012 Mar; 31(9):1130-42. PubMed ID: 21804603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.
    Liao CP; Chen LY; Luethy A; Kim Y; Kani K; MacLeod AR; Gross ME
    Endocr Relat Cancer; 2017 Apr; 24(4):157-170. PubMed ID: 28264911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating tumor reactive stroma by extracorporeal shock waves to control prostate cancer progression.
    Rinella L; Pizzo B; Frairia R; Delsedime L; Calleris G; Gontero P; Zunino V; Fortunati N; Arvat E; Catalano MG
    Prostate; 2020 Sep; 80(13):1087-1096. PubMed ID: 32609927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient-derived fibroblasts.
    Ishii K; Nakagawa Y; Matsuda C; Katoh D; Ichishi M; Shirai T; Hirokawa Y; Fujiwara M; Sugimura Y; Watanabe M
    J Cell Biochem; 2021 Jun; 122(6):679-688. PubMed ID: 33480080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.
    Pereira BA; Lister NL; Hashimoto K; Teng L; Flandes-Iparraguirre M; Eder A; Sanchez-Herrero A; Niranjan B;
    Biomaterials; 2019 Mar; 197():72-85. PubMed ID: 30641266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.